Gene Bridges GmbH

Gene Bridges is an expanding biotech company specialized in innovative DNA engineering technologies. We hold the exclusive rights of its patented Red/ET Recombination technology which we commercialize worldwide. We provide DNA Engineering services, licenses and products for the pharmaceutical, agrobio and biotech industry as well as for academic research institutions.

Activity:

- Contract Research
- Licensing & Business Development
- Manufacturing
- Research & Development
- Other Industry Services

Product / Technology type(s) covered:

- Bio
- Enzymes
- Proteins
- Reagents
- Technology

Therapeutic targets:

Markets Covered

a. HeadQuarter: Germany

b. Continent(s) active: North America , Europe , Asia , Australia/New-Zealand , Near/Middle East , Africa , Central/South America , Far East

c. Countries active: USA, Canada, Germany, UK, France, Japan, Singapore, China, Belgium, Sweden, Finnland, Switzerland

Corporate data:

Number of Employees: 12

Turnover:

Amount:	Year:	Currency:
1,200,000	2001	Euro

Year founded: 2000

Partners / Alliances: Aventis
Biogen